Survivors (n = 54) | Non-survivors (n = 46) | P value | |
---|---|---|---|
Gender female—n (%) | 17 (31.5) | 17 (37.0) | 0.67 |
Site of SIH—n (%) | 0.81 | ||
Lobar | 41 (75.9) | 33 (71.7) | |
Basal ganglia | 3 (5.6) | 4 (8.7) | |
Thalamus | 5 (9.3) | 3 (6.5) | |
Periventricular | 5 (9.3) | 6 (13.0) | |
Cause of SIH—n (%) | 0.07 | ||
Hypertension | 37 (68.5) | 30 (65.2) | |
Amyloid angiopathy | 2 (3.7) | 4 (8.7) | |
Aneurysm | 3 (5.6) | 0 | |
Arteriovenous malformation | 5 (9.3) | 0 | |
OAT in therapeutic range | 3 (5.6) | 6 (13.0) | |
OAT out of therapeutic range | 3 (5.6) | 6 (13.0) | |
Fibrinolytic treatment | 1 (1.9) | 0 | |
Intraventricular hemorrhage—n (%) | 17 (31.5) | 23 (50.0) | 0.07 |
Hydrocephalus—n (%) | 21 (38.9) | 26 (56.5) | 0.11 |
Evacuation SIH—n (%) | 18 (33.3) | 9 (19.6) | 0.18 |
Age (years)—median (p 25–75) | 59 (52–67) | 68 (57–74) | 0.006 |
Volume of SIH (cc)—median (p 25–75) | 38 (17–62) | 68 (29–99) | 0.02 |
Midline shift (mm)—median (p 25–75) | 1 (0–7) | 5 (0–11) | 0.005 |
Sodium (mEq/L)—median (p 25–75) | 139 (137–142) | 139 (135–143) | 0.93 |
Temperature (°C)—median (p 25–75) | 36.9 (36.0–37.4) | 36.5 (35.0–37.0) | 0.10 |
PaO2/FI02 ratio—median (p 25–75) | 270 (189–350) | 289 (215–397) | 0.40 |
Platelets—median*103/mm3 (p 25–75) | 193 (145–252) | 198 (159–270) | 0.57 |
INR—median (p 25–75) | 1.10 (1.00–1.31) | 1.14 (1.02–1.87) | 0.34 |
Lactic acid (mmol/L)-median (p 25–75) | 1.70 (1.00–2.51) | 1.80 (1.30–2.55) | 0.23 |
GCS score—median (p 25–75) | 8 (6–8) | 4 (3–6) | < 0.001 |
Glycemia (g/dL)—median (p 25–75) | 141 (118–190) | 170 (141–216) | 0.01 |
aPTT (s)—median (p 25–75) | 29 (27–32) | 30 (24–34) | 0.68 |
Fibrinogen (mg/dl)—median (p 25–75) | 390 (280–493) | 382 (350–510) | 0.34 |
APACHE-II score—median (p 25–75) | 18 (14–20) | 24 (20–26) | <0.001 |
Creatinine (mg/dl)—median (p 25–75) | 0.77 (0.68–0.90) | 0.80 (0.60–1.01) | 0.36 |
CCCK-18 (u/L)—median (p 25–75) | 129 (112–177) | 291 (212–341) | < 0.001 |